These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30071329)

  • 21. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control.
    Tate DJ; Adler JR; Chang SD; Marquez S; Eulau SM; Fee WE; Pinto H; Goffinet DR
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):915-21. PubMed ID: 10571198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wong FC; Ng AW; Lee VH; Lui CM; Yuen KK; Sze WK; Leung TW; Tung SY
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):138-45. PubMed ID: 19646824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
    Farris JC; Steber CR; Black PJ; Chan MD; Ververs JD; Cramer CK; Browne JD; Waltonen JD; Sullivan CA; Patwa HS; Laxton AW; Tatter SB; Frizzell BA; Porosnicu M; Lycan TW; Greven KM; Hughes RT
    Head Neck; 2022 Nov; 44(11):2571-2578. PubMed ID: 36047613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients.
    Morita A; Coffey RJ; Foote RL; Schiff D; Gorman D
    J Neurosurg; 1999 Jan; 90(1):42-9. PubMed ID: 10413154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
    Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
    J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma knife radiosurgery in the management of cavernous sinus meningiomas.
    Roche PH; Régis J; Dufour H; Fournier HD; Delsanti C; Pellet W; Grisoli F; Peragut JC
    J Neurosurg; 2000 Dec; 93 Suppl 3():68-73. PubMed ID: 11143266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients.
    Fondevilla Soler A; López-Guerra JL; Dzugashvili M; Sempere Rincón P; Sautbaet A; Castañeda P; Díaz JM; Praena-Fernandez JM; Rivin Del Campo E; Azinovic I
    Clin Transl Oncol; 2017 Dec; 19(12):1469-1477. PubMed ID: 28589434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
    McDonald MW; Liu Y; Moore MG; Johnstone PA
    Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.
    Doi H; Kitajima K; Tanooka M; Terada T; Noguchi K; Takada Y; Fujiwara M; Ishikura R; Kamikonya N; Hirota S
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4485-4492. PubMed ID: 27314860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity.
    Mitchell MP; Abboud M; Eng C; Beddar AS; Krishnan S; Delclos ME; Crane CH; Das P
    Am J Clin Oncol; 2014 Oct; 37(5):461-6. PubMed ID: 23466576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
    Moussazadeh N; Lis E; Katsoulakis E; Kahn S; Svoboda M; DiStefano NM; McLaughlin L; Bilsky MH; Yamada Y; Laufer I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):361-7. PubMed ID: 26232858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of nasopharyngeal carcinoma: stereotactic radiosurgical boost following fractionated radiotherapy.
    Chang SD; Tate DJ; Goffinet DR; Martin DP; Adler JR
    Stereotact Funct Neurosurg; 1999; 73(1-4):64-7. PubMed ID: 10853100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.